4.4 Review

Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article

A Qualitative Study of Primary Care Physicians’ Experiences with Telemedicine during the COVID-19 Pandemic in North-Eastern Poland

Karolina Pogorzelska et al.

International Journal of Environmental Research and Public Health (2023)

Review Respiratory System

Continuous glucose monitoring versus self-monitoring of blood glucose in the management of cystic fibrosis related diabetes: A systematic review and meta-analysis

Shanal Kumar et al.

Summary: This systematic review found that the use of continuous glucose monitoring (CGM) may be associated with improved glycemic control in cystic fibrosis-related diabetes (CFRD) compared to self-monitoring of blood glucose (SMBG). However, there is limited evidence on the impact of CGM on pulmonary, non-pulmonary, and quality of life outcomes in CFRD.

JOURNAL OF CYSTIC FIBROSIS (2023)

Article Endocrinology & Metabolism

Paediatric Society and Hyperinsulinism Charity National Surveys on CGM Access for Patients With Recurrent Hypoglycaemia

Sze May Ng et al.

Summary: This study found that access to continuous glucose monitoring (CGM) technology for children and young people in the UK varied greatly. Only 29% of patients were able to access CGM for recurrent hypoglycemia, with 65% of them self-funding. CGM technology has shown benefits in improving quality of life, reducing anxiety, and lessening the burden of frequent finger-pricking, but further research is needed to determine its safety and efficacy in treating hypoglycemic events.

JOURNAL OF THE ENDOCRINE SOCIETY (2023)

Article Endocrinology & Metabolism

Use of the FreeStyle Libre system and diabetes treatment progression in T2DM: Results from a retrospective cohort study using a Canadian private payer claims database

Stewart B. Harris et al.

Summary: A retrospective study using Canadian private drug claims data found that people with type 2 diabetes using the FreeStyle Libre system had a higher probability for treatment progression compared to those using blood glucose monitoring alone, which may improve therapeutic inertia.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Reduced Acute Diabetes Events After FreeStyle Libre System Initiation in People 65 Years or Older with Type 2 Diabetes on Intensive Insulin Therapy in France

Bruno Guerci et al.

Summary: A study conducted in France found that the use of the FreeStyle Libre (R) (FSL) system can significantly reduce the risk of hospitalizations for acute diabetes events in older people with type 2 diabetes on intensive insulin therapy.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Article Endocrinology & Metabolism

Efficacy of intermittent short-term use of a real-time continuous glucose monitoring system in non-insulin-treated patients with type 2 diabetes: A randomized controlled trial

Sun Joon Moon et al.

Summary: This study evaluated the efficacy of intermittent short-term use of a real-time continuous glucose monitoring (RT-CGM) system in non-insulin-treated patients with uncontrolled type 2 diabetes. The results showed that both treatment groups using the RT-CGM system achieved significant HbA1c reduction at 3 and 6 months, particularly in patients performing self-monitoring of blood glucose (SMBG) frequently.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France

Bruno Guerci et al.

Summary: This study demonstrates the significant reduction of ADEs in people with type 2 diabetes in France (on basal insulin only regimen or basal insulin plus non-insulin antidiabetic drugs) through the use of FreeStyle Libre system.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Article Medicine, General & Internal

Flash glucose monitoring in young people with type 1 diabetes-a qualitative study of young people, parents and health professionals: 'It makes life much easier'

Lucy Beasant et al.

Summary: This study explored the experiences of young people and their parents using the Freestyle Libre sensors, as well as the benefits and challenges for healthcare professionals in adopting this technology. The findings showed that flash glucose monitoring improved the confidence and independence of young people in managing their diabetes, and healthcare professionals were enthusiastic about the technology and its potential for tailored patient support.

BMJ OPEN (2023)

Article Endocrinology & Metabolism

The impact of flash glucose monitoring on adults with type 1 Diabetes? eating habits and relationship with food

T. Wallace et al.

Summary: This study explores the influence of the FreeStyle Libre on the eating habits and relationship with food of adults with type 1 diabetes. The findings suggest that the device offers more freedom and flexibility in food choices but also imposes a sense of constant scrutiny. Therefore, addressing patients' relationship with food should be integrated into routine clinic care.

DIABETES RESEARCH AND CLINICAL PRACTICE (2023)

Article Endocrinology & Metabolism

The AH-HA! Project: Transforming Group Diabetes Self-Management Education Through the Addition of Flash Glucose Monitoring

William H. Polonsky et al.

Summary: The findings of this study support a new approach to diabetes self-management education and support (DSMES), which integrates real-time flash glucose monitoring with a highly interactive and engaging patient-driven discovery learning approach.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Review Endocrinology & Metabolism

Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management

Alice P. S. Kong et al.

Summary: The lack of regional continuous glucose monitoring (CGM) recommendations in Asia led to the formulation of evidence-based APAC-specific CGM recommendations by diabetes specialists. The recommendations include defining CGM metrics/targets and guiding-statements for the use of CGM in specific populations and situations. Continual use of CGM is recommended for individuals with diabetes on intensive insulin therapy and suboptimal glycemic control, or at high risk of problematic hypoglycemia.

DIABETES RESEARCH AND CLINICAL PRACTICE (2023)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study

Anagha Champakanath et al.

Summary: Initiating continuous glucose monitoring within the first year of type 1 diabetes diagnosis leads to long-term improvement in A1c levels.

DIABETES CARE (2022)

Review Endocrinology & Metabolism

Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin

Fernando Gomez-Peralta et al.

Summary: Laboratory measured glycated haemoglobin (HbA1c) is the gold standard for assessing glycaemic control, but continuous glucose monitoring (CGM) has revealed limitations of HbA1c testing. The glucose management indicator (GMI) is proposed as a substitute, calculated exclusively from CGM data, but it can differ from HbA1c values.

DIABETES OBESITY & METABOLISM (2022)

Editorial Material Endocrinology & Metabolism

Continuous Glucose Monitoring for Type 2 Diabetes: How Does It Compare with Type 1 Diabetes?

Roy W. Beck et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Article Endocrinology & Metabolism

Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin

Shichun Bao et al.

Summary: The study showed that in older adults (65 years and older) with type 2 diabetes using basal insulin without bolus insulin, real-time continuous glucose monitoring (CGM) resulted in a greater increase in time in range (TIR) and reduction in hyperglycemia compared to blood glucose meter (BGM) monitoring.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Review Endocrinology & Metabolism

Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials

Rosa M. Garcia-Moreno et al.

Summary: This systematic review evaluates the effect of CGM on maternal and neonatal outcomes in GDM, finding that CGM use can lower HbA1c levels in pregnant women, reduce gestational weight gain, and decrease infant birth weight.

DIABETIC MEDICINE (2022)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis

Kevin J. Scully et al.

Summary: This study investigated the correlation between continuous glucose monitoring (CGM) measures and clinical outcomes in adults with cystic fibrosis (CF), as well as the relationship between hemoglobin A1c (HbA1c) and CGM-derived average glucose (AG). The findings suggest that CGM measures of hyperglycemia and glycemic variability are superior to HbA1c in distinguishing those with and without cystic fibrosis-related diabetes (CFRD), with CGM-derived AG strongly correlated with HbA1c in this population. Future research is needed to explore the potential of using CGM as a diagnostic and screening tool for CFRD.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Review Endocrinology & Metabolism

Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis

Anders L. Carlson et al.

Summary: This real-world study and meta-analysis showed that the use of flash glucose monitoring technology led to a significant reduction in HbA1c levels in adults with type 2 diabetes managed with basal insulin. The improvement in HbA1c was observed across different demographics and durations of insulin use.

BMJ OPEN DIABETES RESEARCH & CARE (2022)

Article Endocrinology & Metabolism

Use of Real-Time Continuous Glucose Monitoring Improves Glycemic Control and Other Clinical Outcomes in Type 2 Diabetes Patients Treated with Less Intensive Therapy

Thomas Grace et al.

Summary: This study assessed the clinical effects of using real-time continuous glucose monitoring (rtCGM) in patients with type 2 diabetes (T2D) treated with basal insulin only or noninsulin therapy. The results showed that rtCGM use was associated with significant glycemic improvements. Further research is needed to modify insurance eligibility criteria to expand rtCGM use.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Article Endocrinology & Metabolism

Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study

Jean-Pierre Riveline et al.

Summary: The RELIEF study demonstrates that the use of flash glucose monitoring system effectively reduces hospitalization rates for acute diabetes events, especially DKA, in both type 1 and type 2 diabetes patients. Additionally, there is a clear and progressive decrease in the use of blood glucose test strips over the 2-year period.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Article Endocrinology & Metabolism

Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes

Richard M. Bergenstal et al.

Summary: This study evaluated the effects of structured BGM testing and real-time CGM on glucose control and found that both methods improved A1c control. However, CGM was more effective in reducing the risk of hypoglycemia.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2022)

Editorial Material Pharmacology & Pharmacy

Editorial: Hyperglycemia and Coronary Artery Diseases: Physio-Pathological Findings and Therapeutic Implications

Raffaele Marfella et al.

FRONTIERS IN PHARMACOLOGY (2022)

Article Endocrinology & Metabolism

Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies

Mark Evans et al.

Summary: This meta-analysis confirms that using the FreeStyle Libre system is associated with significant reductions in HbA1c for adults with T1DM or T2DM. The reductions are greater for individuals with higher baseline HbA1c and are sustained for 24 months in T1DM and at least 12 months in T2DM.

DIABETES THERAPY (2022)

Review Medicine, General & Internal

Efficacy of Continuous Glucose Monitoring on Glycaemic Control in Pregnant Women with Gestational Diabetes Mellitus-A Systematic Review

Agata Majewska et al.

Summary: Gestational diabetes mellitus (GDM) is a common complication of pregnancy, affecting up to 14% of pregnant women. Continuous glucose monitoring (CGM) has been shown to be safe and effective in improving glycaemic control in GDM. However, more research is needed to analyze the impact of CGM on perinatal outcomes.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Biochemistry & Molecular Biology

Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer's Disease: Review and Meta-Analysis

Athanasia Athanasaki et al.

Summary: Alzheimer's disease is the most common type of dementia and is closely linked to type 2 diabetes mellitus through various molecular pathways.

BIOMEDICINES (2022)

Article Endocrinology & Metabolism

Gestational and pregestational diabetes in pregnant women with cystic fibrosis

Rachael Oxman et al.

Summary: As CF women increasingly pursue pregnancy, the prevalence of diabetes, including gestational diabetes and CFRD, is high and poses risks to maternal and fetal health. Gestational diabetes is more common in CF women due to lower insulin secretion and higher insulin resistance. Pre-pregnancy counseling, routine screening for CFRD, and optimized glycemic control are recommended. Insulin therapy and CGM can help mitigate risks, and multidisciplinary care is crucial for successful pregnancies.

JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2022)

Article Obstetrics & Gynecology

Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose Monitoring

Michal Fishel Bartal et al.

Summary: This retrospective study compared outcomes between pregnant individuals with time in range (TIR) target ≤70% and >70%. The results showed that achieving a TIR >70% was associated with a reduction in neonatal and maternal complications.

AMERICAN JOURNAL OF PERINATOLOGY (2022)

Article Endocrinology & Metabolism

ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring

Martin Tauschmann et al.

PEDIATRIC DIABETES (2022)

Article Endocrinology & Metabolism

Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study

Michael A. Rotondi et al.

Summary: Universal use of CGM or isCGM in the Canadian T1D population is expected to reduce diabetes-related complications and mortality at an acceptable cost-effectiveness threshold.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring Metrics and Birth Weight: Informing Management of Type 1 Diabetes Throughout Pregnancy

Eleanor M. Scott et al.

Summary: This study analyzed data from 386 pregnant women with type 1 diabetes to determine the relationship between gestational weekly changes in CGM metrics and 24-h glucose profiles and infant birth weight. The results showed that normal birth weight is associated with lower mean CGM glucose concentration and higher time in range from early pregnancy, highlighting the importance of optimizing maternal glycemia early on.

DIABETES CARE (2022)

Article Medicine, General & Internal

Chronic conditions patient's perception of post-COVID-19 pandemic teleconsulting continuation in primary care clinics: a qualitative descriptive study

Marie-Eve Poitras et al.

Summary: This study explored the perspective of patients with chronic diseases on teleconsultation in primary care. Patients expressed high satisfaction with teleconsultation, but there are several issues that need to be addressed. Patients wish to have their opinions heard and considered in the implementation of teleconsultation.

BMJ OPEN (2022)

Review Endocrinology & Metabolism

Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: A systematic review

Shanal Kumar et al.

Summary: Continuous glucose monitoring (CGM) is beneficial in the early detection of cystic fibrosis related diabetes (CFRD) and has been widely used, but using a single reading on CGM to diagnose CFRD is inappropriate. Existing studies have heterogeneity and bias issues, and more prospective studies are needed to determine appropriate thresholds.

JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies et al.

Summary: The American Diabetes Association and the European Association for the Study of Diabetes have updated the consensus statements on the management of hyperglycaemia in type 2 diabetes in adults. The new recommendations focus on social determinants of health, physical activity behaviors, and weight management.

DIABETOLOGIA (2022)

Article Endocrinology & Metabolism

ISPAD clinical practice consensus guidelines 2022: Stages of type 1 diabetes in children and adolescents

Rachel E. J. Besser et al.

PEDIATRIC DIABETES (2022)

Article Health Care Sciences & Services

The societal impact of early intensified treatment in patients with type 2 diabetes mellitus

Foteini Tsotra et al.

Summary: This study estimated the societal impact of early intensified treatment compared with initial monotherapy with subsequent treatment intensification in newly diagnosed adults with type 2 diabetes mellitus in Mexico. The results showed that early treatment intensification significantly reduced complication events and had a positive impact on health outcomes and productivity losses.

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2022)

Article Endocrinology & Metabolism

Intermittently scanned continuous glucose monitoring is associated with lower spontaneous abortion rate compared with conventional blood glucose monitoring in pregnant women with type 1 diabetes: An observational study

Madleen Lemaitre et al.

Summary: This study compares and evaluates the characteristics and outcomes of pregnant women with T1D using isCGM and conventional BGM. The results show that isCGM use is associated with lower spontaneous abortion compared with conventional BGM.

DIABETES & VASCULAR DISEASE RESEARCH (2022)

Article Respiratory System

Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?

Mariana Zorron et al.

Summary: Continuous glucose monitoring is effective in detecting glucose abnormalities in pediatric patients with cystic fibrosis. However, it is not a reliable predictor for the onset of cystic fibrosis-related diabetes. Different diagnostic criteria may be required for patients with cystic fibrosis.

JORNAL BRASILEIRO DE PNEUMOLOGIA (2022)

Article Endocrinology & Metabolism

Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes

Shridhara Alva et al.

Summary: This study evaluated the analytical performance of the second-generation factory-calibrated FreeStyle Libre 2 system compared to the YSI reference. The results showed that the system performed well in terms of accuracy and bias during the 14-day sensor wear period. It demonstrated excellent performance in the hypoglycemic range.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2022)

Article Endocrinology & Metabolism

Impact of Real-Time CGM Data Sharing on Quality of Life in the Caregivers of Adults and Children With Type 1 Diabetes

William H. Polonsky et al.

Summary: Real-time continuous glucose monitoring (RT-CGM) data sharing has a positive impact on caregivers' quality of life and health outcomes, and collaborative actions taken by caregivers further enhance this impact.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2022)

Article Health Care Sciences & Services

Time to Treatment Intensification to Reduce Diabetes-Related Complications: A Post Hoc Study

Piranee Kaewbut et al.

Summary: The study reveals that delaying treatment intensification for patients with type 2 diabetes for even 6 months or more increases the likelihood of developing diabetic nephropathy.

HEALTHCARE (2022)

Article Medicine, General & Internal

Stress-Induced Hyperglycemia: Consequences and Management

Deepanjali Vedantam et al.

Summary: Hyperglycemia during stress is common in hospitalized patients, caused by insulin resistance and decreased insulin secretion. This article compiles various studies to discuss the development, consequences, and impact of SIH on acute illnesses. It evaluates the management of SIH with insulin and proper nutritional therapy and emphasizes the importance of formulating a discharge plan.

CUREUS JOURNAL OF MEDICAL SCIENCE (2022)

Editorial Material Pharmacology & Pharmacy

Is avoidance of hypoglycaemia a better target than HbA1C in older people with diabetes?

Katharina Mattishent et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Review Endocrinology & Metabolism

Current cancer therapies and their influence on glucose control

Carly Yim et al.

Summary: This review focuses on the development of hyperglycemia caused by four commonly used cancer therapy drug classes, highlighting differences in characteristics among these classes and variations in the incidence and severity of new onset hyperglycemia.

WORLD JOURNAL OF DIABETES (2021)

Article Endocrinology & Metabolism

Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study

Timothy R. Gilbert et al.

Summary: The study indicated a significant decrease in HbA1c levels and a reduction in psychological distress and hypoglycemic concerns during the first few months of CGM use. Most participants expressed satisfaction with the G6 System and found it easy to use.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Review Endocrinology & Metabolism

Personal Continuous Glucose Monitoring Use Among Adults with Type 2 Diabetes: Clinical Efficacy and Economic Impacts

Tamara K. Oser et al.

Summary: Recent studies show that CGM has clinical benefits in T2D, especially in patients treated with insulin. CGM is more effective in reducing HbA1c levels, hypoglycemia, and hyperglycemia compared to SMBG, with patients showing a preference for and acceptance of CGM.

CURRENT DIABETES REPORTS (2021)

Article Endocrinology & Metabolism

The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Richard I. G. Holt et al.

Summary: This article discusses a consensus statement on the management of type 1 diabetes in adults, covering various aspects such as diagnosis, treatment goals, self-management education and support, with the aim of helping healthcare professionals better manage patients with this condition.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

Maternal glucose variability during pregnancy & birthweight percentile in women with pre-gestational diabetes

Nimrod Dori-Dayan et al.

Summary: This study found an association between maternal glucose variability indices (SD and CV) during pregnancy and neonatal birth percentile, particularly showing a positive correlation between SD and CV with birthweight percentile.

GYNECOLOGICAL ENDOCRINOLOGY (2021)

Review Multidisciplinary Sciences

Diabetes, stroke, and neuroresilience: looking beyond hyperglycemia

Matthew J. Krinock et al.

Summary: Ischemic stroke is a leading cause of morbidity and mortality among type 2 diabetic patients. Most clinical trials have focused on treating hyperglycemia alone, but Pioglitazone has shown promise in secondary stroke prevention in insulin-resistant patients. Further research into clinical therapies targeting diabetic pathophysiological processes is necessary.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2021)

Article Endocrinology & Metabolism

Sustainable Use of a Real-Time Continuous Glucose Monitoring System from 2018 to 2020

Joost van der Linden et al.

Summary: The study aimed to analyze CGM usage patterns and glycemic outcomes from 2018 to 2020 in a real-world cohort of G6 system users. Results showed high rates of persistent use, lower incidence of hypoglycemia, higher TIR, and significantly fewer calibrations in 2019 and 2020 compared to G5 use. High persistence and utilization of the G6 system may lead to sustainable glycemic outcomes and reduce user burden.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Medicine, General & Internal

Flash glucose monitoring in gestational diabetes mellitus: study protocol for a randomised controlled trial

Agata Majewska et al.

Summary: Gestational diabetes mellitus (GDM) is a common condition in pregnant women, impacting both maternal and fetal health. The study aims to assess the impact of flash glucose monitoring (FGM) on the efficacy of treatment in GDM patients. The prospective study will compare FGM and self-monitoring of blood glucose groups in terms of glycaemic control and maternal/neonatal outcomes.

BMJ OPEN (2021)

Article Endocrinology & Metabolism

Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study

Ronan Roussel et al.

Summary: The RELIEF study in France found that hospitalizations for acute diabetes complications decreased significantly after the initiation of the FreeStyle Libre system, including a reduction in DKA and diabetes-related comas. The study also showed a marked decrease in hospitalizations among individuals who were noncompliant with SMBG and those with the highest SMBG acquisition prior to starting FreeStyle Libre. Overall, the use of flash glucose monitoring could have important implications for improving patient-centered diabetes care and long-term health economic outcomes.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes

Dulce Adelaida Rivera-Avila et al.

Summary: Professional continuous glucose monitoring has been shown to reduce HbA1c levels and improve glycemic control in patients with type 2 diabetes, with additional benefits seen in dietary patterns.

BMC ENDOCRINE DISORDERS (2021)

Review Environmental Sciences

Flash Glucose Monitoring and Patient Satisfaction: A Meta-Review of Systematic Reviews

Ana Diez-Fernandez et al.

Summary: This meta-review aimed to evaluate the effects of FGM systems on patient satisfaction and quality of life in type 1 and type 2 diabetes patients. Despite some evidence suggesting improvements in patient satisfaction and quality of life with FGM systems, more high-quality research is needed due to the variability in measurement tools and uncertainty in the quality of systematic reviews included in the analysis.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Environmental Sciences

Glycaemic Variability and Risk Factors of Pregnant Women with and without Gestational Diabetes Mellitus Measured by Continuous Glucose Monitoring

Martina Gaborova et al.

Summary: This study compared the glycaemic variability of pregnant women with and without gestational diabetes mellitus (GDM) using continuous glucose monitoring (CGM) and found a significant difference in total AUC between the two groups. The risk factors of GDM were correlated with parameters of glycaemic control, indicating that pregnant women with these risk factors are more likely to have severe glycaemic variability.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Review Endocrinology & Metabolism

The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study

Tom Elliott et al.

Summary: This study aimed to evaluate the impact of Flash glucose monitoring on glucose control in type 2 diabetes patients, finding a significant decrease in HbA1c in patients using basal insulin after using the device, with improvements not significantly associated with age, BMI, insulin use duration, or sex.

DIABETES & VASCULAR DISEASE RESEARCH (2021)

Article Endocrinology & Metabolism

Glucose Patterns in Very Old Adults: A Pilot Study in a Community-Based Population

Elizabeth Selvin et al.

Summary: This study evaluated CGM patterns in very old adults, finding high feasibility and acceptability of CGM in this population. Low readings on CGM are common, even in nondiabetic older adults, and the clinical relevance of these low values requires further investigation.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations

Timothy S. Bailey et al.

Summary: Continuous glucose monitoring devices have been significantly improved with better sensor accuracy, leading to FDA approval of nonadjunctive use. This is important for informed clinical decision-making regarding current systems' performance characteristics and regulatory classifications.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus

George Grunberger et al.

Summary: This article summarizes the evidence-based recommendations of AACE on the use of advanced technology in the management of diabetes, including 37 clinical practice recommendations informed by 357 citations. The study highlights that advanced diabetes technology can improve self-management capabilities and quality of life for patients, as well as enhance the efficiency and effectiveness of clinical decision-making.

ENDOCRINE PRACTICE (2021)

Article Medicine, General & Internal

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin A Randomized Clinical Trial

Thomas Martens et al.

Summary: Continuous glucose monitoring (CGM) was more effective in reducing HbA1c levels at 8 months compared to blood glucose meter (BGM) monitoring in adults with poorly controlled type 2 diabetes treated with basal insulin without prandial insulin. Participants using CGM also showed better time in target glucose range and lower mean glucose values.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Endocrinology & Metabolism

Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial

David A. Price et al.

Summary: In this pilot study, limited episodic real-time continuous glucose monitoring (rtCGM) use in individuals failing multiple non-insulin therapies resulted in modest, short-term glycemic benefits. However, these benefits were not sustained in the long run.

DIABETES THERAPY (2021)

Review Endocrinology & Metabolism

The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond

Pratik Choudhary et al.

Summary: Telemedicine in diabetes care has been evolving, especially during the COVID-19 pandemic where remote monitoring devices have shown to improve glucose control for patients. However, challenges in Europe include fragmented approaches to technology assessment and reimbursement, lack of eHealth education and data integration, as well as concerns about electronic health records and privacy. Despite these challenges, efforts are being made to ensure the value of eHealth services is provided to patients, healthcare providers, and health systems in the future.

DIABETES THERAPY (2021)

Review Endocrinology & Metabolism

Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future

Thomas Danne et al.

Summary: People with diabetes are at greater risk for negative outcomes from COVID-19, but remote monitoring of glucose metrics has been shown to improve glycemic control. The use of telemedicine in diabetes care helps alleviate the burden on diabetes clinics and should be more widely accessible.

DIABETES THERAPY (2021)

Article Pediatrics

Continuous Glucose Monitoring as a Valuable Tool in the Early Detection of Diabetes Related to Cystic Fibrosis

Bojana Gojsina et al.

Summary: The study evaluated the impact of cystic fibrosis-related diabetes (CFRD) on lung disease and nutritional status. It was found that continuous glucose monitoring is a useful tool for insight into glucose impairment and diagnosis of CFRD, and early recognition and therapeutic intervention of CFRD has favorable effects on the clinical course of the disease.

FRONTIERS IN PEDIATRICS (2021)

Article Health Care Sciences & Services

Flash CGM Associated With Event Reduction in Nonintensive Diabetes Therapy

Eden Miller et al.

Summary: The study showed that the acquisition of a flash CGM system was associated with significant reductions in acute diabetes-related events and all-cause inpatient hospitalizations in patients with type 2 diabetes treated with basal insulin therapy or noninsulin therapy.

AMERICAN JOURNAL OF MANAGED CARE (2021)

Article Endocrinology & Metabolism

Identification of maternal continuous glucose monitoring metrics related to newborn birth weight in pregnant women with gestational diabetes

Song-Ying Shen et al.

Summary: This study aimed to identify specific glucose metrics from maternal continuous glucose monitoring data associated with a higher percentile of offspring birth weight. Results showed that maternal nighttime mean glucose level and HSSV were significantly associated with an increase in birth weight percentile, while no associations were found for other glucose metrics.

ENDOCRINE (2021)

Review Endocrinology & Metabolism

Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM

Ralph Ziegler et al.

Summary: Intermittent use of continuous glucose monitoring (CGM) is introduced in the article as an application expanding typical medical use cases, emphasizing its temporary benefits and possibilities, particularly for economic reasons and limited resources.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)

Article Endocrinology & Metabolism

Effect of Professional CGM (pCGM) on Glucose Management in Type 2 Diabetes Patients in Primary Care

Gregg D. Simonson et al.

Summary: The study found that using professional CGM in the management of type 2 diabetes, combined with lifestyle counseling and therapy intensification, significantly improved glycemic control, reduced A1C levels, increased time in range, and decreased time in hyperglycemia.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)

Article Endocrinology & Metabolism

Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes

Richard M. Bergenstal et al.

Summary: Flash continuous glucose monitoring (flash CGM) has been shown to improve glycemic control in type 1 and type 2 diabetes patients, leading to reduced risks of acute and chronic complications, which subsequently decrease emergency department visits and hospitalizations.

JOURNAL OF THE ENDOCRINE SOCIETY (2021)

Article Endocrinology & Metabolism

Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France

Stephane Roze et al.

Summary: The study aimed to determine the long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system compared to self-monitoring of blood glucose in adults with type 1 diabetes in France. Results showed that the G6 RT-CGM system led to an incremental gain in quality-adjusted life expectancy and was cost-effective relative to SMBG, primarily driven by improved glycemic control and quality of life benefits.

DIABETES THERAPY (2021)

Article Geriatrics & Gerontology

Cognitive Dysfunction in Older Adults with Type 2 Diabetes Links, Risks, and Clinical Implications

Alan Sinclair et al.

CLINICS IN GERIATRIC MEDICINE (2020)

Review Endocrinology & Metabolism

Glycemic Monitoring and Management in Advanced Chronic Kidney Disease

Rodolfo J. Galindo et al.

ENDOCRINE REVIEWS (2020)

Article Health Care Sciences & Services

Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes

Christina H. Sherrill et al.

Journal of Managed Care & Specialty Pharmacy (2020)

Article Obstetrics & Gynecology

The outcome of pregnancy in women with cystic fibrosis: a UK population-based descriptive study

A. Ashcroft et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2020)

Editorial Material Endocrinology & Metabolism

Cystic fibrosis-related diabetes: The unmet need

Leonardo Pozo et al.

WORLD JOURNAL OF DIABETES (2020)

Review Endocrinology & Metabolism

Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment

Cresio Alves et al.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2020)

Article Endocrinology & Metabolism

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

Roy W. Beck et al.

DIABETES CARE (2019)

Review Endocrinology & Metabolism

Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: Implications for clinical practice

Ramzi A. Ajjan et al.

DIABETES & VASCULAR DISEASE RESEARCH (2018)

Article Endocrinology & Metabolism

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

N. H. Cho et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2018)

Article Endocrinology & Metabolism

Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor Applicator

Viral N. Shah et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Article Endocrinology & Metabolism

Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study

Sara Charleer et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Review Endocrinology & Metabolism

Effectiveness and acceptability of continuous glucose monitoring for type 2 diabetes management: A narrative review

Pennie J. Taylor et al.

JOURNAL OF DIABETES INVESTIGATION (2018)

Article Endocrinology & Metabolism

Therapeutic inertia amongst general practitioners with interest in diabetes

Samuel Seidu et al.

PRIMARY CARE DIABETES (2018)

Editorial Material Endocrinology & Metabolism

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

Richard M. Bergenstal et al.

DIABETES CARE (2018)

Article Biochemistry & Molecular Biology

Glucotypes reveal new patterns of glucose dysregulation

Heather Hall et al.

PLOS BIOLOGY (2018)

Article Endocrinology & Metabolism

New-onset diabetes after kidney transplantation: Incidence and associated factors

Vania Gomes et al.

WORLD JOURNAL OF DIABETES (2018)

Review Endocrinology & Metabolism

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review

Kamlesh Khunti et al.

DIABETES OBESITY & METABOLISM (2018)

Review Endocrinology & Metabolism

Gestational diabetes from A to Z

AbdelHameed Mirghani Dirar et al.

WORLD JOURNAL OF DIABETES (2017)

Article Endocrinology & Metabolism

International Consensus on Use of Continuous Glucose Monitoring

Thomas Danne et al.

DIABETES CARE (2017)

Review Oncology

Impact of hyperglycemia on the efficacy of chemotherapy-A systematic review of preclinical studies

Maaike C. Gerards et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

Article Public, Environmental & Occupational Health

Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis

Emily T. Martin et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2016)

Article Endocrinology & Metabolism

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin

K. Khunti et al.

DIABETES OBESITY & METABOLISM (2016)

Article Medicine, General & Internal

Variations of blood glucose in cancer patients during chemotherapy

J. Yang et al.

NIGERIAN JOURNAL OF CLINICAL PRACTICE (2016)

Article Cardiac & Cardiovascular Systems

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

Sanjoy K. Paul et al.

CARDIOVASCULAR DIABETOLOGY (2015)

Article Endocrinology & Metabolism

Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: The DIALYDIAB pilot study

Michael Joubert et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2015)

Article Endocrinology & Metabolism

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

Timothy Bailey et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2015)

Article Endocrinology & Metabolism

The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients

Lauren Buehler et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)

Review Endocrinology & Metabolism

Update on cognitive decline and dementia in elderly patients with diabetes

L. Bordier et al.

DIABETES & METABOLISM (2014)

Article Endocrinology & Metabolism

HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes The Diabetes and Aging Study

Kasia J. Lipska et al.

DIABETES CARE (2013)

Article Medicine, General & Internal

Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis

Atsushi Goto et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

Review Health Care Sciences & Services

Social Stigma in Diabetes A Framework to Understand a Growing Problem for an Increasing Epidemic

Jasmin Schabert et al.

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2013)

Article Medicine, General & Internal

Frequent Hypoglycemia Among Elderly Patients With Poor Glycemic Control

Medha N. Munshi et al.

ARCHIVES OF INTERNAL MEDICINE (2011)

Article Endocrinology & Metabolism

Correlates of Quality of Life in Older Adults With Diabetes The Diabetes & Aging Study

Neda Laiteerapong et al.

DIABETES CARE (2011)

Article Endocrinology & Metabolism

Diabetes as a Determinant of Mortality in Cystic Fibrosis

Parinya Chamnan et al.

DIABETES CARE (2010)

Article Endocrinology & Metabolism

Cystic Fibrosis-Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality

Antoinette Moran et al.

DIABETES CARE (2009)

Article Health Care Sciences & Services

Reasons for not intensifying medications: Differentiating Clinical inertia from appropriate care

Monika M. Safford et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2007)

Article Endocrinology & Metabolism

Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy

Helen R. Murphy et al.

DIABETES CARE (2007)

Article Public, Environmental & Occupational Health

Birth weight and subsequent risk of type 2 diabetes: A meta-analysis

Thomas Harder et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)

Article Endocrinology & Metabolism

Frequency and risk factors of severe hypoglycemia in insulin-treated type 2 diabetes: a literature survey

Kamran Akram et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)

Article Endocrinology & Metabolism

Psychological insulin resistance in patients with type 2 diabetes - The scope of the problem

WH Polonsky et al.

DIABETES CARE (2005)

Article Medicine, General & Internal

Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands

IN Evers et al.

BMJ-BRITISH MEDICAL JOURNAL (2004)

Article Public, Environmental & Occupational Health

The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients

R Latham et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2001)

Article Geriatrics & Gerontology

Diabetes in elderly adults

GS Meneilly et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2001)